BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 3289114)

  • 21. Prevalence of Campylobacter pylori in duodenal and gastric mucosa--relationship to inflammation.
    Johnston BJ; Reed PI; Ali MH
    Scand J Gastroenterol Suppl; 1988; 142():69-75. PubMed ID: 3166535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Campylobacter pyloric, chronic gastritis, gastric ulcer and duodenal ulcer].
    Ramírez-Ramos A; Recavarren-Arce S; León-Barúa R; Gilman R; Spira W; Watanabe-Yamamoto J; Garrido-Klinge G; Cok-García J; Zevallos-Coronado E; Rodríguez-Ulloa C
    Arq Gastroenterol; 1987; 24(1):10-5. PubMed ID: 3329902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Campylobacter pyloridis, gastritis, and peptic ulceration.
    Goodwin CS; Armstrong JA; Marshall BJ
    J Clin Pathol; 1986 Apr; 39(4):353-65. PubMed ID: 3517070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance of Campylobacter pylori.
    Dooley CP; Cohen H
    Ann Intern Med; 1988 Jan; 108(1):70-9. PubMed ID: 3276266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A method of determining Campylobacter pylori in the gastric mucosa in peptic ulcer and chronic gastritis].
    Grigor'ev PIa; Isakov VA; Rozental' VM; Agrba VZ; Tananaeva IK
    Lab Delo; 1989; (6):52-4. PubMed ID: 2474707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Campylobacter pylori in duodenal ulcer--a concomitant phenomenon or causal association?].
    Malfertheiner P; Bode G; Stanescu A; Ditschuneit H
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():112-8. PubMed ID: 3310428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Campylobacter pylori. Diagnosis and treatment.
    Tytgat GN; Rauws EA; de Koster EH
    J Clin Gastroenterol; 1989; 11 Suppl 1():S49-53. PubMed ID: 2681390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of Campylobacter pylori and gastritis in the stomach of patients with and without duodenal ulcer.
    Queiroz DM; Barbosa AJ; Mendes EN; Rocha GA; Cisalpino EO; Lima GF; Oliveira CA
    Am J Gastroenterol; 1988 Dec; 83(12):1368-70. PubMed ID: 3195542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Campylobacter pylori (C. pylori): an occasional finding or a constant pathogenetic factor in peptic and inflammatory gastroduodenal pathology? Personal observations].
    Licata A; Naso P; Bartoloni G; Bonanno G; Di Gaetano G; Torcetta N
    Minerva Dietol Gastroenterol; 1990; 36(3):133-7. PubMed ID: 2280870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiology of Campylobacter pylori].
    Mai U; Opferkuch W
    Leber Magen Darm; 1988 Feb; 18(1):31-7. PubMed ID: 3280931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice].
    Simon L; Tornóczky J; Tóth M; Jámbor M; Sudár Z
    Orv Hetil; 1989 Jun; 130(25):1325-9. PubMed ID: 2664637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphology of chronic gastritis associated with Campylobacter pylori infection].
    Sancho Poch FJ; Sainz Sáenz-Torre S; Monés Xiol J; González Juan D; Mirelis B; Vilardell Viñas F
    Rev Esp Enferm Apar Dig; 1989 Dec; 76(6 Pt 1):551-4. PubMed ID: 2623310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria.
    Graham DY; Alpert LC; Smith JL; Yoshimura HH
    Am J Gastroenterol; 1988 Sep; 83(9):974-80. PubMed ID: 3414650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Campylobacter pylori and its role in peptic ulcer disease.
    Tytgat GN; Rauws EA
    Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Campylobacter pylori, gastritis and ulcer. Where are we going now?].
    Wadström T; Ljungh A
    Nord Med; 1990; 105(1):24-6. PubMed ID: 2405351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of Campylobacter pylori in the clinical course of chronic antral gastritis and duodenal ulcer].
    Kalinin AV; Spesivtsev VN; Sedletskiĭ VA; Belogolovtsev VA
    Klin Med (Mosk); 1989 Oct; 67(10):64-6. PubMed ID: 2615309
    [No Abstract]   [Full Text] [Related]  

  • 40. Campylobacter pylori and peptic ulcer disease.
    Graham DY
    Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):615-25. PubMed ID: 2642447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.